• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glucocorticoids in rheumatoid arthritis still on first line: the reasons.

作者信息

Cutolo Maurizio, Paolino Sabrina, Gotelli Emanuele

机构信息

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties, University of Genova, IRCCS San Martino Polyclinic, Genova, Italy.

出版信息

Expert Rev Clin Immunol. 2021 May;17(5):417-420. doi: 10.1080/1744666X.2021.1903319. Epub 2021 Mar 19.

DOI:10.1080/1744666X.2021.1903319
PMID:33706640
Abstract
摘要

相似文献

1
Glucocorticoids in rheumatoid arthritis still on first line: the reasons.糖皮质激素在类风湿关节炎中仍处于一线用药地位：原因
Expert Rev Clin Immunol. 2021 May;17(5):417-420. doi: 10.1080/1744666X.2021.1903319. Epub 2021 Mar 19.
2
Circadian rhythms and rheumatoid arthritis.昼夜节律与类风湿关节炎。
Joint Bone Spine. 2019 May;86(3):327-333. doi: 10.1016/j.jbspin.2018.09.003. Epub 2018 Sep 15.
3
Morning glucocorticoids versus night glucocorticoids: the role of low-dose glucocorticoid chronotherapy in rheumatoid arthritis.早晨糖皮质激素与夜间糖皮质激素：低剂量糖皮质激素时间疗法在类风湿关节炎中的作用
J Clin Rheumatol. 2014 Dec;20(8):437-9. doi: 10.1097/RHU.0000000000000182.
4
[Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?].[糖皮质激素在类风湿性关节炎中的应用：几乎总是使用还是几乎从不使用？]
Reumatol Clin. 2011 Nov-Dec;7(6):407-11. doi: 10.1016/j.reuma.2011.01.008. Epub 2011 May 18.
5
Is There a Renaissance of Glucocorticoids in Rheumatoid Arthritis?类风湿关节炎中糖皮质激素的复兴？
Clin Pharmacol Ther. 2017 Oct;102(4):574-577. doi: 10.1002/cpt.753. Epub 2017 Aug 7.
6
Matching therapy to body rhythms: an endocrine approach to treating rheumatoid arthritis.使治疗与身体节律相匹配：一种治疗类风湿性关节炎的内分泌方法。
J Rheumatol. 2010 Oct;37(10):1981-2. doi: 10.3899/jrheum.100688.
7
A fresh look at glucocorticoids how to use an old ally more effectively.重新审视糖皮质激素：如何更有效地利用这个老盟友。
Bull NYU Hosp Jt Dis. 2012;70 Suppl 1:26-9.
8
The use of glucocorticoids in rheumatoid arthritis--no 'rational' approach yet.类风湿关节炎中糖皮质激素的应用——尚无“合理”方法。
Arthritis Res Ther. 2010;12(3):127. doi: 10.1186/ar3035. Epub 2010 Jun 25.
9
Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al.使用糖皮质激素或改善病情抗风湿药治疗能否降低类风湿关节炎的影像学进展速率？对Abu-Shakra等人文章的评论
Arthritis Rheum. 1999 May;42(5):1066-7. doi: 10.1002/1529-0131(199905)42:5<1066::aid-anr30>3.0.co;2-z.
10
[Disease-modifying effects of glucocorticoids in rheumatoid arthritis].[糖皮质激素对类风湿关节炎的病情改善作用]
Z Rheumatol. 2007 Oct;66(6):522-4. doi: 10.1007/s00393-007-0185-1.

引用本文的文献

1
Individual Cortisol Production in Active Rheumatoid Arthritis Associates with Treatment Responses: A Pilot, Two-Year Study.活动性类风湿关节炎患者的个体皮质醇分泌与治疗反应的关系：一项为期两年的初步研究。
Mediterr J Rheumatol. 2025 May 28;36(2):193-199. doi: 10.31138/mjr.131224.ipc. eCollection 2025 Jun.
2
Pharmacological modes of plant-derived compounds for targeting inflammation in rheumatoid arthritis: A comprehensive review on immunomodulatory perspective.植物源化合物靶向类风湿关节炎炎症的药理模式：基于免疫调节视角的综述
Inflammopharmacology. 2025 Apr;33(4):1537-1581. doi: 10.1007/s10787-025-01664-7. Epub 2025 Mar 13.
3
High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.
高累积糖皮质激素剂量与活动期类风湿关节炎中炎症相关介质水平升高有关。
Front Immunol. 2024 Dec 18;15:1505615. doi: 10.3389/fimmu.2024.1505615. eCollection 2024.
4
Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study.类风湿关节炎中皮质醇的日间分泌与治疗反应预测：一项 6 个月的真实前瞻性队列研究。
RMD Open. 2024 Jan 17;10(1):e003575. doi: 10.1136/rmdopen-2023-003575.
5
The dichotomy of glucocorticosteroid treatment in immune-inflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice.免疫炎症性风湿疾病中糖皮质激素治疗的二分法：基于证据的观点及临床实践见解
Reumatologia. 2023;61(4):283-293. doi: 10.5114/reum/170845. Epub 2023 Aug 31.
6
Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.糖皮质激素、作用、性别二态性与疾病：新概念、新机制与新发现。
Physiol Rev. 2024 Jan 1;104(1):473-532. doi: 10.1152/physrev.00021.2023. Epub 2023 Sep 21.
7
Identifying hub circadian rhythm biomarkers and immune cell infiltration in rheumatoid arthritis.鉴定类风湿关节炎中枢纽生物钟生物标志物和免疫细胞浸润。
Front Immunol. 2022 Sep 27;13:1004883. doi: 10.3389/fimmu.2022.1004883. eCollection 2022.
8
Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis.经皮传递调控炎症因子的药物治疗类风湿关节炎。
Drug Deliv. 2022 Dec;29(1):1934-1950. doi: 10.1080/10717544.2022.2089295.
9
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.csDMARDs 联合治疗对类风湿关节炎患者一线 TNF 抑制剂药物持久性的有益影响：来自捷克 ATTRA 登记处的数据。
Rheumatol Int. 2022 May;42(5):803-814. doi: 10.1007/s00296-021-05072-2. Epub 2022 Mar 26.
10
CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.CTLA4-Ig 治疗可诱导健康受试者和类风湿关节炎患者来源的单核细胞衍生巨噬细胞中 M1-M2 转换。
Arthritis Res Ther. 2021 Dec 24;23(1):306. doi: 10.1186/s13075-021-02691-9.